Scientists are researching if a drug that’s being tested to treat a skin condition can also help keep COVID-19 patients off ventilators. The drug, labeled as EDP1815, was being tested on psoriasis patients, but Dr. Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, said it will now be tested on coronavirus patients who have pneumonia and inflammation of the lungs. To read the full article.
Recent Posts
- He made his brothers get their arteries checked. Each had advanced heart disease.
- Yibin Kang’s team identifies new path to potential cancer treatments.
- Why a Life-Threatening Sedative Is Being Prescribed More Often for Seniors.
- NJACTS Community Engagement Core Available Services
- Join NJ ACTS for a Seminar on Clinical Research Record Retention on 3/2 at 12
Categories
- Community (2,444)
- Covid (997)
- CTO Events (6)
- News (3,097)
- Pilots (21)